Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker PCSA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | PCSA Processa Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2026 | PCSA Processa Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2026 | PCSA Processa Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 5, 2026 | PCSA Processa Pharmaceuticals, Inc. | 8.01 Other Events | 8-K/A | 8-K ↗ |
| Aug 4, 2026 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Aug 4, 2026 | PCSA Processa Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jul 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Jul 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jul 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Jul 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 29, 2026 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 19, 2026 | PCSA Processa Pharmaceuticals, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 7, 2026 | PCSA Processa Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 15, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Dec 15, 2025 | PCSA Processa Pharmaceuticals, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Sep 16, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K/A | 8-K ↗ |
| Sep 16, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K/A | 8-K ↗ |
| Sep 12, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Sep 10, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Sep 2, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Aug 25, 2025 | PCSA Processa Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 14, 2025 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K/A | 8-K ↗ |
| Aug 14, 2025 | PCSA Processa Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K/A | 8-K ↗ |
| Aug 14, 2025 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K/A | 8-K ↗ |
| Aug 8, 2025 | PCSA Processa Pharmaceuticals, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Aug 7, 2025 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 7, 2025 | PCSA Processa Pharmaceuticals, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Aug 7, 2025 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 25, 2025 | PCSA Processa Pharmaceuticals, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 18, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jul 15, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jul 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 30, 2025 | PCSA Processa Pharmaceuticals, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 30, 2025 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 18, 2025 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 18, 2025 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 17, 2025 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 17, 2025 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 11, 2025 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 10, 2025 | PCSA Processa Pharmaceuticals, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jan 30, 2025 | PCSA Processa Pharmaceuticals, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 30, 2025 | PCSA Processa Pharmaceuticals, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 6, 2024 | PCSA Processa Pharmaceuticals, Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
48 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:12 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances